Navigation Links
Regado Biosciences to Present at the Annual UBS Global Life Sciences Conference in New York City
Date:9/14/2011

and the second being its complementary active control agent (anivamersen, a.k.a. RB007).  Anivamersen can be used to selectively completely or partially reverse the anticoagulant effect of pegnivacogin.  REG1, having recently completed phase 2b clinical development (the RADAR trial), is intended for application in arterial thrombosis indications, such as Acute Coronary Syndrome patients undergoing Percutaneous Coronary Intervention.  A clinical program in Open Heart Surgery [including coronary artery bypass grafting (CABG) and valve repair/replacement] is also under development.  REG2, Regado's second product candidate, consists of a subcutaneously administered depot formulation of pegnivacogin paired with the IV bolus formulation of anivamersen.  REG2 recently completed single escalating dose phase 1 clinical testing (the first successful subcutaneous application of an aptamer in humans) and is planned to be studied in a multiple escalating dose clinical trial in 2011.  It is intended for use in venous thrombosis indications such as venous thromboembolism (VTE) prophylaxis in patients undergoing abdominal surgery.  REG3, Regado's third program, consists of a specific GPVI inhibitor and its active control agent (RB571 and RB515, respectively).  REG3 is planned to enter phase 1 human clinical testing in 2011 and will be indicated for antiplatelet therapy.  Information pertaining to Regado's clinical programs may be obtained at www.clinicaltrials.gov.

ABOUT APTAMERS

Pegnivacogin is a member of a class of compounds called aptamers.  Aptamers are single stranded oligonucleotides that adopt a specific conformation enabling direct, specific inhibition of the targeted protein.  A key unique feature of aptamers derives from the fact that they are formed from nucleic acids.  As such, their pharmacologic activity can be controlled by a matched, complem
'/>"/>

SOURCE Regado Biosciences
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System
2. Regado Biosciences to Present at the Needham & Companys 10th Annual Healthcare Conference in New York City
3. Regado Biosciences, Inc. Announces Presentation of the Results of the RADAR Phase 2b Clinical Trial of Its Anticoagulant System REG1 at the i2 Summit During the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans
4. Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City
5. Regado Biosciences, Inc. Introduces REG3, a Novel Aptamer-Based Inhibitor of Glycoprotein VI and its Matched Active Control Agent, at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
6. Regado Biosciences, Inc. Presents Pharmacokinetic and Pharmacodynamic (PK/PD) Substudy Results From its Phase 2b RADAR Trial at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
7. Regado Biosciences, Inc. Presents Two Abstracts on the Subcutaneous Depot Formulation of Pegnivacogin, a Nuclease-Stabilized RNA Aptamer, Direct Factor IXa Inhibitor and Part of the REG2 Anticoagulant System, at the American Heart Association (AHA)
8. Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania
9. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
10. Regado Biosciences to Present at the Stifel Nicolaus Healthcare Conference 2010 on September 16, 2010 in Boston, Massachusetts
11. Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)...  Bruin Biometrics (BBI), a pioneer in biometric-sensor ... weeks of clinical briefings to over 200 pressure ... substantial concurrence on both the clinical validity of ... BBI,s SEM Scanner. "From our ... drawn from the European Wound Management Association (EWMA) ...
(Date:7/24/2014)... July 24, 2014  Bayer HealthCare today announced ... evaluated a 15% foam formulation of its compound ... inflammatory papules and pustules of rosacea. An AzA ... complement the currently available AzA gel formulation. Papulopustular ... (papules and pustules) as well as erythema (redness) ...
(Date:7/24/2014)... , July 24, 2014  Market Diagnostics ... IVD Insights™ LabFile , a data resource ... US clinical laboratory universe and identifying target In ... a proprietary database that provides IVD manufacturers with ... tests, relying on clear and consistent definitions of ...
Breaking Medicine Technology:Bruin Biometrics Secures Support of EU Scientific Community for its SEM Scanner Technology 2Phase III Investigational Trial of Azelaic Acid 15% Foam Meets Both Co-Primary Endpoints in Subjects with Papulopustular Rosacea 2Phase III Investigational Trial of Azelaic Acid 15% Foam Meets Both Co-Primary Endpoints in Subjects with Papulopustular Rosacea 3MDxI Launches Data Resource Setting New Standard for Defining and Targeting US Clinical Laboratory Universe 2
... June 18, 2007 /PRNewswire/ -- Today, results,from ... comparing two angiotensin,receptor blockers (ARBs) in hypertensive ... 17th annual European Meeting on,Hypertension in Milan, ... parallel group,multicenter study included 860 hypertensive patients,(>130/80mmHg) ...
... 2007 --- Millipore Corporation today announced the release ... lines. The,research was conducted by the Department ... plc, whose ReNcell,distribution agreement with Millipore was announced ... Dr. Vi Chu, research &,development scientist for Millipore’s ...
Cached Medicine Technology:New Data Presented on Micardis (Telmisartan) Tablets in,Hypertensive Patients With Type 2 Diabetes 2New Data Presented on Micardis (Telmisartan) Tablets in,Hypertensive Patients With Type 2 Diabetes 3New Data Presented on Micardis (Telmisartan) Tablets in,Hypertensive Patients With Type 2 Diabetes 4Millipore Corporation Announces New ReNcell Data from Collaboration,with ReNeuron 2Millipore Corporation Announces New ReNcell Data from Collaboration,with ReNeuron 3Millipore Corporation Announces New ReNcell Data from Collaboration,with ReNeuron 4
(Date:7/24/2014)... The North American air and missile defense ... and is expected to register a CAGR of 8.22% to ... biggest market for the air and missile defense radar system. ... witnessed budget cuts as well. , Browse through the TOC ... report, to get an idea of the in-depth analysis provided. ...
(Date:7/24/2014)... -- Even though its use is often advised by doctors, ... not help treat lower back pain, according to a new ... no more effective than a dummy pill for more than ... showing no effect in easing discomfort, the study also found ... to back pain, nor did it improve patients, overall quality ...
(Date:7/24/2014)... emergency departments can be reduced by enabling patients to ... doctor,s surgery. This is just one of several recommendations ... at the University of Bristol. , Called ,Primary care ... reviews, the report has been compiled by researchers from ... at evidence from studies around the world. They found ...
(Date:7/24/2014)... have identified two previously undescribed radiological signs ... gastric bands. Adding widespread knowledge of the ... margin by more than 2.4 cm from ... air-fluid,level above the band on a frontal ... in diagnosing affected bariatric patients. These signs ...
(Date:7/24/2014)... neonicotinoids, were found commonly in streams throughout the ... is the first broad-scale investigation of neonicotinoid insecticides ... the first conducted within the United States. , ... pests, use of neonicotinoid insecticides has dramatically increased ... particularly in the Midwest. The use of ...
Breaking Medicine News(10 mins):Health News:North America Air and Missile Defense Radar Market is Expected to Reach $2.7 Billion in 2020 - New Report by MicroMarket Monitor 2Health News:North America Air and Missile Defense Radar Market is Expected to Reach $2.7 Billion in 2020 - New Report by MicroMarket Monitor 3Health News:North America Air and Missile Defense Radar Market is Expected to Reach $2.7 Billion in 2020 - New Report by MicroMarket Monitor 4Health News:Acetaminophen May Not Help Against Back Pain, Study Contends 2Health News:Acetaminophen May Not Help Against Back Pain, Study Contends 3Health News:Seeing the same GP at every visit will reduce emergency department attendance 2Health News:Corn & soy insecticides similar to nicotine found widespread in Midwest rivers -- USGS news 2
... a twin are at upto 5 times higher risk of suffering ... was conducted on over 800 pairs of twins in the UK ... age of 40 was 3-5 times higher in twins than women ... ten years or earlier than the usual period. Only 1-in-100 women ...
... The diagnosis of Kylie Minogue with breast cancer has led to ... get breast cancer//. ,Cancer Research UK said that ... strike the under-70s than women over 70,. ,Their survey ... that a woman's risk of breast cancer was increased if she ...
... toddlers, reports a major study conducted on the side effects of ... proposed immunization for all kids of the age 6 months to ... sharp rise in the number of children getting vaccinated. This proposal ... years as often as the old people. ,This study ...
... A 1-year-old girl has been diagnosed with polio in spite ... an official statement, polio can be prevented by 4-10 doses ... this girl called Jannat. ,“Earlier she used to ... Jannat's Mother, Akhbari Khatun says.,Jannat was diagnosed with polio just ...
... from heart surgery. A Researcher from the University of Calary has ... Kathryn King, in her research informs that those who wore ... and discomfort, when compared those who were in a ... to the Canadian Cardiovascular Congress in Vancouver after two years of ...
... A recent research proposes that radiations from handsets may affect fertility ... count than normal.// ,A study conducted on 361 ... the daily mobile use by the man, there was a decrease ... a 40% reduction in sperm count in men who used mobile ...
Cached Medicine News:Health News:Mobile use increases risk of infertility in men 2
1 mm wide by 28 mm long sterling silver blade. Flat serrated handle with polished finish....
Double ended lasik spatula with flattened tip for lifting and smoothing the corneal flap. The sharp tip is useful to outline a previous flap in preparation for retreatment....
Serrated rake tip spatula with 20 gauge shaft. Black finish for reduced glare. Can be used with 20 gauge MVR blades....
Rounded tip spatula with 20 gauge shaft. Black finish for reduced glare....
Medicine Products: